The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up

BACKGROUND: Recently risedronate is suggested to be effective for the prevention and treatment of for osteoporosis in total hip arthroplasty. This meta-analysis aimes to evaluate the efficacy of risedronate in reducing femoral periprosthetic bone mineral density loss in patients undergoing primary t...

Descripción completa

Detalles Bibliográficos
Autor principal: Yang, Liqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904972/
https://www.ncbi.nlm.nih.gov/pubmed/29665839
http://dx.doi.org/10.1186/s13018-018-0808-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904972/
https://www.ncbi.nlm.nih.gov/pubmed/29665839
http://dx.doi.org/10.1186/s13018-018-0808-z

Ejemplares similares